Colin Giles
Directeur/Membre du Conseil chez Morris Animal Foundation
Profil
Colin Giles is currently the Treasurer & Trustee at Morris Animal Foundation.
He previously worked as the Vice President-Clinical & Regulatory Affairs at Nexvet Biopharma Plc and Nexvet Australia Pty Ltd.
He also worked as the Vice President-Veterinary Medicine Pharmaceuticals at Zoetis, Inc. Dr. Giles received his undergraduate and doctorate degrees from The Royal Veterinary College.
Postes actifs de Colin Giles
| Sociétés | Poste | Début |
|---|---|---|
Morris Animal Foundation
 Morris Animal Foundation Miscellaneous Commercial ServicesCommercial Services Morris Animal Foundation operates as an animal health charity. It helps support the advancement of veterinary medicine and funds veterinary research for companion animals, horses, and wildlife. The company was founded by Mark Morris Sr. in 1948 and is headquartered in Denver, CO. | Directeur/Membre du Conseil | - |
Anciens postes connus de Colin Giles
| Sociétés | Poste | Fin |
|---|---|---|
Nexvet Australia Pty Ltd.
 Nexvet Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Nexvet Australia Pty Ltd. operates as a global clinical-stage biopharmaceutical company that develops and distributes medicines for companion animals. The firm focuses on transforming the therapeutic market by developing and commercializing novel biologic therapies, including products derived from its PETization technology. PETization is designed to rapidly create monoclonal antibodies that are recognized as “self” by a patient’s immune system. The company was founded by Mark Heffernan, Christopher Nigel Brown and David Gearing in February 2010 and is headquartered in Melbourne, Australia. | Directeur Technique/Scientifique/R&D | 01/11/2017 |
| NEXVET BIOPHARMA PUBLIC LIMITED CO | Directeur Technique/Scientifique/R&D | - |
| ZOETIS INC. | Corporate Officer/Principal | - |
Formation de Colin Giles
| The Royal Veterinary College | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ZOETIS INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Nexvet Australia Pty Ltd.
Nexvet Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Nexvet Australia Pty Ltd. operates as a global clinical-stage biopharmaceutical company that develops and distributes medicines for companion animals. The firm focuses on transforming the therapeutic market by developing and commercializing novel biologic therapies, including products derived from its PETization technology. PETization is designed to rapidly create monoclonal antibodies that are recognized as “self” by a patient’s immune system. The company was founded by Mark Heffernan, Christopher Nigel Brown and David Gearing in February 2010 and is headquartered in Melbourne, Australia. | Health Technology |
Morris Animal Foundation
Morris Animal Foundation Miscellaneous Commercial ServicesCommercial Services Morris Animal Foundation operates as an animal health charity. It helps support the advancement of veterinary medicine and funds veterinary research for companion animals, horses, and wildlife. The company was founded by Mark Morris Sr. in 1948 and is headquartered in Denver, CO. | Commercial Services |
Nexvet Biopharma Plc
 Nexvet Biopharma Plc Pharmaceuticals: MajorHealth Technology Nexvet Biopharma Plc engaged in the provision of integrated biopharmaceutical business. It focused on transforming the therapeutic market for companion animals, such as dogs and cats, by developing and commercializing novel, species-specific biologics. The company was founded in September 2014 and was headquartered in Dublin, Ireland. | Health Technology |
